Yocon (Yohimbine HCl)

Medically reviewed by Melisa Puckey. Last updated on May 19, 2025

YOCON®

Glenwood

Yohimbine HCl

Sympatholytic

Indications And Clinical Uses: As an alpha-adrenergic blocking agent.

Contra-Indications: Renal or hepatic insufficiency.

Precautions: Yohimbine may cause hypotension. It should not be administered to geriatric patients, psychiatric patients or cardiorenal patients with a history of gastric or duodenal ulcer.

Symptoms And Treatment Of Overdose: Treatment: Conduct gastric lavage and administer activated charcoal (4 tablespoonfuls: 500 mL of water). Treat excitation or convulsions with a barbiturate.

Dosage: Adults: 1 tablet up to 3 times daily or as directed by a physician.

Availability And Storage: Each white, uncoated, spherical tablet contains: yohimbine HCl 5.4 mg. Nonmedicinal ingredients: colloidal silicon dioxide NF, dibasic calcium phosphate dihydrate USP, magnesium stearate NF, microcrystalline cellulose NF, sodium starch glycolate NF, stearic acid NF and talc USP. Bottles of 100 and 1 000. (Shown in Product Recognition Section)

YOCON® Glenwood Yohimbine HCl Sympatholytic

About Melisa Puckey

Melisa Puckey, BPharm is a New Zealand–registered pharmacist accredited to supply emergency contraception, sildenafil, trimethoprim, chloramphenicol, and clozapine. She has over ten years of experience in community pharmacy, focusing on patient care, medication safety, and treatment accuracy. Her medical writing centers on evidence-based topics including COVID-19, oncology, dermatology, and reproductive health. Melisa is a member of the Pharmaceutical Society of New Zealand, the Australasian Medical Writers' Association, and the American Medical Writers Association.